SCHEMBL12374652

SCHEMBL12374652

Cc1c(C(=O)/C=C/c2ccccc2)c(=O)n(C)c2ccccc12

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PADI4 Q9UM07 7/20 0.60
NPC1 O15118 3/20 0.50
RAB9A P51151 3/20 0.50
KMT2A Q03164 3/20 0.50
CYP3A4 P08684 2/20 0.50
MAPT P10636 2/20 0.50
MEN1 O00255 1/20 0.50
LMNA P02545 1/20 0.50
CYP1A2 P05177 1/20 0.50
CYP2D6 P10635 1/20 0.50
CYP2C9 P11712 1/20 0.50
CYP2C19 P33261 1/20 0.50
HTT P42858 1/20 0.50
JAK2 O60674 1/20 0.50
PAX8 Q06710 1/20 0.50
ALDH1A1 P00352 3/20 0.48
CYP1B1 Q16678 1/20 0.48
ABCG2 Q9UNQ0 1/20 0.46
KDM4E B2RXH2 1/20 0.45
ABCB1 P08183 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12374862 0.89 PADI4 (0.51) PADI4NPC1RAB9AKMT2AMAPT
SCHEMBL12374654 0.86 LMNA (0.49) PADI4NPC1RAB9AKMT2ACYP3A4
SCHEMBL12374696 0.82 KMT2A (0.52) PADI4NPC1RAB9AKMT2ACYP3A4
SCHEMBL29701 0.81 ALDH1A1 (0.59) NPC1RAB9AKMT2AMEN1LMNA
SCHEMBL23467988 0.77 PADI4 (0.78) PADI4KMT2ALMNA
SCHEMBL1884535 0.77 ALDH1A1 (0.58) PADI4NPC1RAB9AKMT2ACYP3A4
SCHEMBL14288822 0.77 ALDH1A1 (0.71) NPC1RAB9AKMT2AMEN1LMNA
SCHEMBL12374651 0.77 PADI4 (0.65) PADI4NPC1RAB9AKMT2AMAPT
SCHEMBL23468020 0.76 PADI4 (1.00) PADI4CYP3A4ABCG2
SCHEMBL12374650 0.76 KMT2A (0.54) PADI4NPC1RAB9AKMT2ACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8524729-B2 Cinnamoyl derivatives and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2013-09-03 US disclosed
US-7989478-B2 decreases expression of a Type I collage gene in a tissue to induce a reduction in accumulation of collagen and thereby improves tissue fibrosis SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-08-02 US disclosed
US-20070123521-A1 Cinnamoyl derivatives and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070123521-A1 Cinnamoyl derivatives and use thereof CES2, EBP, CPT1A PADI4 2457/4885NPC1 4/4885RAB9A 3002/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.